SCPX
Price
$0.14
Change
+$0.01 (+7.69%)
Updated
Apr 2 closing price
Capitalization
799.18K
VRCA
Price
$0.44
Change
-$0.00 (-0.00%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
40.24M
34 days until earnings call
Ad is loading...

SCPX vs VRCA

Header iconSCPX vs VRCA Comparison
Open Charts SCPX vs VRCABanner chart's image
SCORPIUS HOLDINGS
Price$0.14
Change+$0.01 (+7.69%)
Volume$187.76K
Capitalization799.18K
Verrica Pharmaceuticals
Price$0.44
Change-$0.00 (-0.00%)
Volume$10.01K
Capitalization40.24M
SCPX vs VRCA Comparison Chart
Loading...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCPX vs. VRCA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCPX is a Hold and VRCA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (SCPX: $0.14 vs. VRCA: $0.44)
Brand notoriety: SCPX and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCPX: 18% vs. VRCA: 0%
Market capitalization -- SCPX: $799.18K vs. VRCA: $40.24M
SCPX [@Biotechnology] is valued at $799.18K. VRCA’s [@Biotechnology] market capitalization is $40.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCPX’s FA Score shows that 1 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • SCPX’s FA Score: 1 green, 4 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, SCPX is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCPX’s TA Score shows that 5 TA indicator(s) are bullish while VRCA’s TA Score has 4 bullish TA indicator(s).

  • SCPX’s TA Score: 5 bullish, 3 bearish.
  • VRCA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SCPX is a better buy in the short-term than VRCA.

Price Growth

SCPX (@Biotechnology) experienced а -12.71% price change this week, while VRCA (@Biotechnology) price change was -7.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

SCPX is expected to report earnings on Nov 11, 2024.

VRCA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRCA($40.2M) has a higher market cap than SCPX($799K). VRCA YTD gains are higher at: -36.829 vs. SCPX (-58.182). SCPX has higher annual earnings (EBITDA): -22.84M vs. VRCA (-65.9M). VRCA has more cash in the bank: 46.3M vs. SCPX (4.81M). SCPX has less debt than VRCA: SCPX (14.9M) vs VRCA (45.9M). SCPX has higher revenues than VRCA: SCPX (10M) vs VRCA (7.57M).
SCPXVRCASCPX / VRCA
Capitalization799K40.2M2%
EBITDA-22.84M-65.9M35%
Gain YTD-58.182-36.829158%
P/E RatioN/AN/A-
Revenue10M7.57M132%
Total Cash4.81M46.3M10%
Total Debt14.9M45.9M32%
FUNDAMENTALS RATINGS
SCPX vs VRCA: Fundamental Ratings
SCPX
VRCA
OUTLOOK RATING
1..100
5451
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9695
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPX's Valuation (8) in the Biotechnology industry is significantly better than the same rating for VRCA (96) in the Pharmaceuticals Major industry. This means that SCPX’s stock grew significantly faster than VRCA’s over the last 12 months.

SCPX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SCPX’s stock grew similarly to VRCA’s over the last 12 months.

SCPX's SMR Rating (98) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SCPX’s stock grew similarly to VRCA’s over the last 12 months.

VRCA's Price Growth Rating (95) in the Pharmaceuticals Major industry is in the same range as SCPX (96) in the Biotechnology industry. This means that VRCA’s stock grew similarly to SCPX’s over the last 12 months.

VRCA's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as SCPX (100) in the Biotechnology industry. This means that VRCA’s stock grew similarly to SCPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCPXVRCA
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 23 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIG3.320.15
+4.73%
Transocean Ltd
GM47.260.23
+0.49%
General Motors Company
UG9.000.01
+0.11%
United-Guardian
PHR25.46-0.10
-0.39%
Phreesia
OABI2.28-0.12
-5.00%
OmniAb